Prevalence of Misophonia in Turkish High School Students

March 12, 2026 updated by: Handan Turan Dizdar, Ondokuz Mayıs University

Prevalence of Misophonia in Turkish High School Students: A Sample From Kayseri and Samsun

This cross-sectional study aims to determine the prevalence of misophonia among high school students in Kayseri and Samsun, Turkey. Data will be collected using a sociodemographic data form and the Amsterdam Misophonia Scale-Revised (AMISOS-R). The study will evaluate the frequency and severity of misophonia symptoms and examine their association with demographic variables.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Misophonia is a condition characterized by decreased tolerance and heightened sensitivity to specific sounds. It is more closely related to the character of the sound than to its intensity and is often reported to begin during childhood or early adolescence. Misophonia may negatively affect students' social interactions and academic performance, particularly in school environments where exposure to auditory stimuli is unavoidable.

This cross-sectional descriptive prevalence study aims to determine the prevalence and severity of misophonia among high school students in Kayseri and Samsun, Turkey. The study population will include students in grades 9 through 12 attending selected high schools. Students with hearing loss, chronic illness, severe psychological disorders, intellectual disabilities, or those outside the defined age range will be excluded.

Data will be collected using a sociodemographic data form and the 10-item Amsterdam Misophonia Scale-Revised (AMISOS-R), a validated self-report instrument assessing the presence and severity of misophonia symptoms. Statistical analyses will be conducted to evaluate the distribution of misophonia symptoms and their associations with demographic variables. The study will be conducted in accordance with ethical principles.

Study Type

Observational

Enrollment (Estimated)

600

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Kayseri, Turkey (Türkiye)
        • Recruiting
        • Selected High Schools in Kayseri
      • Samsun, Turkey (Türkiye)
        • Recruiting
        • Selected High Schools in Samsun

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

High school students in grades 9 through 12 from selected schools in Kayseri and Samsun, Turkey.

Description

Inclusion Criteria:

  • Students enrolled in grades 9 through 12
  • Students without diagnosed hearing loss
  • Students without chronic illness
  • Students without severe psychological disorders

Exclusion Criteria:

  • Students with diagnosed hearing loss
  • Students with any chronic illness
  • Students with severe psychological disorders
  • Students outside the defined age range
  • Students who are illiterate
  • Students with intellectual disabilities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of misophonia in high school students
Time Frame: Baseline (single assessment)
The proportion of high school students identified as having misophonia based on predefined classification criteria using the Amsterdam Misophonia Scale-Revised (AMISOS-R). The AMISOS-R total score ranges from 0 to 40, with higher scores indicating greater misophonia severity. Misophonia classification is determined according to established cutoff values.
Baseline (single assessment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Severity levels of misophonia symptoms
Time Frame: Baseline (single assessment)
Distribution of students according to misophonia severity levels (normal, mild, moderate, and severe) based on the Amsterdam Misophonia Scale-Revised (AMISOS-R). The AMISOS-R total score ranges from 0 to 40, with higher scores indicating more severe misophonia symptoms.
Baseline (single assessment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Asya Sıla Alacahan, Ondokuz Mayıs University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 25, 2025

Primary Completion (Estimated)

April 1, 2026

Study Completion (Estimated)

April 1, 2026

Study Registration Dates

First Submitted

February 24, 2026

First Submitted That Met QC Criteria

March 12, 2026

First Posted (Actual)

March 13, 2026

Study Record Updates

Last Update Posted (Actual)

March 13, 2026

Last Update Submitted That Met QC Criteria

March 12, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024/581

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Misophonia

Subscribe